BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4629818)

  • 1. Therapy with cephaloridine in renal impairment.
    Bechtol LD
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):790-800. PubMed ID: 4629818
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nil nocere. On the problem of the nephrotoxicity of cephaloridine].
    Straube W; König K
    Munch Med Wochenschr; 1969 Mar; 111(12):665-9. PubMed ID: 5819271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cephaloridine. Adjustment of its dosage to the degree of renal insufficiency and administration during chronic uremia treated by repeated hemodialysis].
    Brogard JM; Ruscher H; Frankhauser J; Jahn H; Dammron A
    Ann Med Interne (Paris); 1970 Dec; 121(12):1027-38. PubMed ID: 5504233
    [No Abstract]   [Full Text] [Related]  

  • 4. Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity.
    Perkins RL; Apicella MA; Lee IS; Cuppage FE; Saslaw S
    J Lab Clin Med; 1968 Jan; 71(1):75-84. PubMed ID: 4965437
    [No Abstract]   [Full Text] [Related]  

  • 5. Doxycycline in renal insufficiency.
    Kasanen A; Raines T; Sundqvist H; Tikkanen R
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):243-50. PubMed ID: 4206732
    [No Abstract]   [Full Text] [Related]  

  • 6. Excretion of cephaloridine and cephalothin in patients with renal impairment.
    Kunin CM; Atuk N
    N Engl J Med; 1966 Mar; 274(12):654-6. PubMed ID: 17926378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of a new antibiotic: cephaloridine].
    De Petra V
    Clin Ter; 1967 Jul; 42(2):147-62. PubMed ID: 5596413
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of blood urea nitrogen and serum creatinine levels following cephaloridine administration (author's transl)].
    Hasumi M; Kashiwagi K; Amano M
    Jpn J Antibiot; 1981 Jul; 34(7):1106-12. PubMed ID: 7321190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cephaloridine in reduced kidney function].
    Neuhaus G; Willbrandt R; Fritz KW; Lange A; Volkening R
    Med Welt; 1971 Jul; 22(29):1209-12. PubMed ID: 5566157
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of cephalothin].
    Höffler D; Koeppe P; Fuchs E; Fiegel P
    Verh Dtsch Ges Inn Med; 1971; 77():1019-22. PubMed ID: 5005541
    [No Abstract]   [Full Text] [Related]  

  • 11. Kidney function tests in chronic renal disease. Serum urea nitrogen, creatinine, and creatine clearance.
    Patton RB; Remp D
    Henry Ford Hosp Med J; 1968; 16(2):185-7. PubMed ID: 5650039
    [No Abstract]   [Full Text] [Related]  

  • 12. Half-life of cephaloridine in dogs with reduced renal function.
    Klausner JS; Meunier PC; Osborne CA; Stevens JB; Stowe CM
    Am J Vet Res; 1977 Aug; 38(8):1191-5. PubMed ID: 911088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Doxycycline (Vibramycin) in restricted renal function].
    Porpáczy P
    Wien Klin Wochenschr; 1970 Oct; 82(41):710-4. PubMed ID: 5480598
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of renal function from the blood urea and serum creatinine concentrations.
    Wing AJ
    East Afr Med J; 1969 May; 46(5):329-33. PubMed ID: 5345971
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of [Determination of phenolsulphonphthalein in the plasma of beagles as a kidney function test. Studies on healthy and on sublimate-poisoned animals].
    Jahn W; Lorenz D
    Arzneimittelforschung; 1972 Oct; 22(10):1670-80. PubMed ID: 4677054
    [No Abstract]   [Full Text] [Related]  

  • 16. Cephaloridine in patients with impaired renal function.
    Dillon ML; Postlewait RW
    JAMA; 1971 Oct; 218(2):251-2. PubMed ID: 5109962
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacologic studies with minocycline.
    Bernard B; Yin EJ; Simon HJ
    J Clin Pharmacol New Drugs; 1971; 11(5):332-48. PubMed ID: 4998431
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxycycline (Vibramycin) in chronic renal failure.
    Letteri JM; Miraflor F; Tablante V; Siddiqi S
    Nephron; 1973; 11(5):318-24. PubMed ID: 4584946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reversible drug-induced uremia in chronic kidney diseases].
    Minetti L; De Min A; Grossi C; Torelli D
    Minerva Nefrol; 1976; 23(1):19-24. PubMed ID: 995327
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.